0.3902
Milestone Scientific Inc. stock is traded at $0.3902, with a volume of 103.44K.
It is down -2.94% in the last 24 hours and up +25.91% over the past month.
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
See More
Previous Close:
$0.402
Open:
$0.42
24h Volume:
103.44K
Relative Volume:
0.29
Market Cap:
$34.51M
Revenue:
$8.90M
Net Income/Loss:
$-4.57M
P/E Ratio:
-7.018
EPS:
-0.0556
Net Cash Flow:
$-1.84M
1W Performance:
-10.71%
1M Performance:
+25.91%
6M Performance:
+28.44%
1Y Performance:
-34.42%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Name
Milestone Scientific Inc.
Sector
Industry
Phone
973-535-2717
Address
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MLSS
Milestone Scientific Inc.
|
0.3902 | 34.51M | 8.90M | -4.57M | -1.84M | -0.0556 |
|
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-16-20 | Initiated | Northland Capital | Market Perform |
| Nov-16-18 | Reiterated | Maxim Group | Buy |
| Dec-23-16 | Reiterated | Maxim Group | Buy |
| Dec-11-15 | Initiated | Maxim Group | Buy |
Milestone Scientific Inc. Stock (MLSS) Latest News
Milestone Scientific expects Q2 revenue of $2.8M - MSN
Top Five Milestones in Space Exploration History - Encyclopedia Britannica
Milestone's Milo AI Pilot Will Answer Questions at ASPN 2026 - Stock Titan
China’s Long March 10B rocket successfully launches—and lands—in a global spaceflight milestone - Scientific American
NewcelX Appoints Diabetes Research Leader Camillo Ricordi to Scientific Advisory Board Following FDA Pre-IND Milestone - Quiver Quantitative
Milestone Scientific Inc. Q1 2026 Earnings: Narrower Than Expected Loss, Stock SlipsOperating Income Trends - dars.gov.et
Price to sales forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
MLSSMilestone Scientific Inc Dividends - Finviz
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline - dars.gov.et
Milestone Scientific (MLSS) Slides 2.34% as Stock Tests Key Support LevelsVolume Weighted Price - dars.gov.et
Benchmark reiterates Milestone Scientific stock Speculative Buy on Q2 beat By Investing.com - Investing.com Nigeria
Benchmark reiterates Milestone Scientific stock Speculative Buy on Q2 beat - Investing.com
Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1 - Moomoo
MLSS News | MILESTONE SCIENTIFIC INC (NYSEARCA:MLSS) - ChartMill
Milestone Scientific expects Q2 revenue of ~$2.8M, up 21% YoY - scanx.trade
MLSS Reports Strong Revenue Growth in Medical Segment - GuruFocus
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY - The Manila Times
Milestone Scientific's preliminary Q2 revenue rises on base business expansion - TradingView
Milestone Scientific Inc. Provides Earnings Guidance for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Price to earnings forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Milestone Scientific (MLSS) Hovers Near Key Support at $0.30 as Selling Pressure PersistsPercent Below MA - DonanımHaber
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift StockReturn On Capital - dars.gov.et
Enterprise value to revenue forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Enterprise value to EBIT forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Enterprise value to EBITDA forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Milestone Scientific Inc. Actuals & Estimates (AMEX:MLSS) - TradingView
Milestone Scientific Inc (MLSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Milestone Scientific Inc (MLSS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MLSS Forecast — Price Target — Prediction for 2027 - TradingView
Milestone Scientific Inc. Announces Board Changes - marketscreener.com
Milestone Scientific adds two directors, transitions board chair By Investing.com - Investing.com Nigeria
Milestone Scientific Strengthens Board with Healthcare and Finance Experts to Drive Strategic Growth - Minichart
Milestone Scientific adds two directors, transitions board chair - Investing.com
Milestone Scientific Restructures Leadership and Governance Agreements - TipRanks
Milestone Scientific Strengthens Board to Support Next Phase of Growth - marketscreener.com
Milestone Scientific (MLSS) revamps board, names Executive Chair and restructures founder deal - Stock Titan
Press Release: Milestone Scientific Strengthens Board to Support Next Phase of Growth - Moomoo
Milestone Scientific Inc. (MLSS) Edges Higher as Stock Tests Key ResistanceArms Index - dars.gov.et
Milestone Scientific Inc (MLSS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form DEF 14A Milestone Scientific Inc. For: 22 June By Investing.com - Investing.com South Africa
[DEF 14A] MILESTONE SCIENTIFIC INC. Definitive Proxy Statement - Stock Titan
Milestone Scientific (MLSS) Surges 9.24% as Shares Approach ResistanceCatalyst Driven Stocks - dars.gov.et
Milestone Scientific Inc (MLSS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Milestone Scientific Inc (MLSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Milestone Scientific Inc (MLSS) Institutional Confidence - TradingKey
Milestone Scientific Inc (MLSS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Milestone Scientific Inc (MLSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Milestone Scientific Inc (MLSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss as EPS Surprises to the UpsideEarnings Weakness Phase - Bölüm Sonu Canavarı
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss and Positive SurpriseBalance Sheet Strength - newsline.com
Milestone Scientific Inc. Stock (MLSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):